Wuxi Hyatech Co

Wuxi Hyatech Co Financial Leverage

The Financial Leverage (Equity Multiplier) of Wuxi Hyatech Co (688510.SS) as of Oct 22, 2026 is 1.67. In the previous year, Financial Leverage (Equity Multiplier) was 1.68 — a change of -0.49% (lower).

Financial Leverage

1.67

YoY

-0.49%

Last updated:

Financial Leverage (Equity Multiplier) of Wuxi Hyatech Co is 2025 1.67 . Financial Leverage (Equity Multiplier) of Wuxi Hyatech Co was 2024 1.68 . It decreases by -0.49% lower compared to the previous year.

The Wuxi Hyatech Co Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2018
1.46 CNY
Jan 1, 2019
1.55 CNY
Jan 1, 2020
1.29 CNY
Jan 1, 2021
1.42 CNY
Jan 1, 2022
1.51 CNY
Jan 1, 2023
1.51 CNY
Jan 1, 2024
1.68 CNY
Jan 1, 2025
1.67 CNY
The Wuxi Hyatech Co Financial Leverage history
YEARFinancial LeverageYoY
1.67-0.49%
1.68+11.03%
1.51+0.37%
1.51+6.16%
1.42+10.14%
1.29-16.76%
1.55+5.75%
1.46-18.57%
1.80+2.79%
1.75+26.25%
1.38-33.51%
2.08—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Wuxi Hyatech Co Stock analysis

What does Wuxi Hyatech Co do? Wuxi Hyatech Co Ltd generates revenue through the research and development, manufacturing, and sales of key components for aero-engines and medical orthopedic implant forgings. The company produces high-performance components including aviation turbofan engine compressor blades, rotating parts, and structural parts, which are sold domestically and internationally. Its primary customers are aerospace manufacturers and medical device companies requiring specialized forgings for engine parts and orthopedic implants. The firm targets the aerospace and medical sectors with its focus on precision-engineered components for critical applications. The company's product portfolio includes aviation turbofan engine compressor blades, rotating parts, and structural parts, alongside medical orthopedic implant forgings. These products are distributed across domestic and overseas markets, serving both the Chinese aerospace industry and international medical device markets. Wuxi Hyatech's revenue streams are derived from direct sales of these specialized components to industrial and medical clients without third-party intermediaries. Wuxi Hyatech's business model centers on supplying high-precision components for aero-engines and medical orthopedic implants. The company's manufacturing capabilities enable it to produce critical parts for aircraft engines and orthopedic devices, with a focus on domestic and international industrial clients. Revenue is generated through the sale of these specialized forgings to aerospace and medical sectors, leveraging its R&D expertise in component production. Wuxi Hyatech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Wuxi Hyatech Co stock

Financial Leverage (Equity Multiplier) of Wuxi Hyatech Co is 1.67 in 2025.

Financial Leverage (Equity Multiplier) of Wuxi Hyatech Co changed from 1.68 to 1.67, representing a -0.49% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Wuxi Hyatech Co since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Wuxi Hyatech Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Wuxi Hyatech Co

All Key Metrics — Wuxi Hyatech Co